Atrion (NASDAQ:ATRI – Get Rating) and Integra LifeSciences (NASDAQ:IART – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, analyst recommendations, earnings and institutional ownership. Analyst Ratings This is a summary of recent ratings and price […]
Wall Street brokerages expect Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) to announce earnings per share (EPS) of $0.80 for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Integra LifeSciences’ earnings, with the lowest EPS estimate coming in at $0.79 and the highest estimate coming in at $0.81. […]
Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) EVP Lisa Evoli sold 250 shares of the firm’s stock in a transaction dated Tuesday, May 24th. The stock was sold at an average price of $59.85, for a total transaction of $14,962.50. Following the transaction, the executive vice president now owns 20,811 shares of the company’s […]
Integra LifeSciences (NASDAQ:IART – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Saturday. IART has been the subject of a number of other research reports. Bank of America raised their price objective on Integra LifeSciences from $55.00 to $65.00 and gave the company […]
Wall Street brokerages predict that Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) will post $0.68 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Integra LifeSciences’ earnings, with the lowest EPS estimate coming in at $0.67 and the highest estimate coming in at […]